CCL5 and stroke disorder: Previous findings imply that aging may alter the immunological response to ischemic brain injury, characterized by higher CCL5/RANTES concentrations and increased neutrophil chemotaxis [19]; however, the extent that these age-related changes alter stroke outcomes is unknown.